IREN
IREN Limited
There isn't enough reported data to score IREN yet.
MCB
Metropolitan Bank Holding Corp.
MCB's fundamentals are strong: revenue grew 24% and its operating margin rose 12 points to 43%. At 9.9x earnings, it's trading in line with its usual 11x. Analysts expect earnings growth.
IREN Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Weak | |
| N/A | |
| N/A |
IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.
MCB Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
MCB's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like MCB.
IREN PE Valuation
IREN has no meaningful PE right now: it lost money over the past year.
MCB PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 7.4x | $72.70 | -25% |
| Forward | 9x | $97.11 | — |
| Current | 9.9x | $97.11 | — |
| Fair | 11x | $105 | +8.4% |
| Expensive | 13x | $132 | +35% |
Historical ranges are pointers, not guarantees.
MCB's PE is in its fair range at 9.9x. If earnings grow as analysts expect, today's price would be 9.0x next year's earnings.
IREN Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.
MCB Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Improving | |
| Limited | |
| High |
MCB has the edge over IREN on the outlook, with more favorable earnings expectations.
IREN Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$3.96 | -347% |
| Q2 2026 | -$2.22 | -988% |
| Q1 2026 | $0.51 | +$1.10 |
| Q4 2025 | $1.18 | +$1.62 |
| Q3 2025 | $1.60 | +$1.99 |
| Q2 2025 | $0.25 | +$0.45 |
| Q1 2025 | -$0.59 | -$0.43 |
| Q4 2024 | -$0.44 | -$0.15 |
IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.
MCB Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.76 | +10% |
| Q3 2026 | $9.78 | +69% |
| Q2 2026 | $7.87 | +27% |
| Q1 2026 | $8.09 | +37% |
| Q4 2025 | $6.62 | +12% |
| Q3 2025 | $5.77 | +7.6% |
| Q2 2025 | $6.18 | -1.1% |
| Q1 2025 | $5.92 | -3.3% |
| Q4 2024 | $5.93 | -14% |
MCB has the edge over IREN on earnings quality, reporting a profit while its opponent remains loss making.
IREN Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $228M | -5.1% |
| Q2 2026 | $137.2M | -27% |
| Q1 2026 | $144.8M | 0% |
| Q4 2025 | $184.7M | +59% |
| Q3 2025 | $240.3M | +355% |
| Q2 2025 | $187.3M | +230% |
| Q1 2025 | $144.8M | +168% |
| Q4 2024 | $116.1M | +176% |
IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -82% | -50 points |
| Q2 2026 | -452% | -461 points |
| Q1 2026 | -161% | -180 points |
| Q4 2025 | -63% | -79 points |
| Q3 2025 | -32% | +57 points |
| Q2 2025 | 9% | +49 points |
| Q1 2025 | 19% | +8 points |
| Q4 2024 | 15% | +21 points |
IREN's operating margin was −82% last quarter, down 50 points from the same quarter a year ago.
MCB Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $100.6M | +26% |
| Q2 2026 | $93M | +22% |
| Q1 2026 | $88.5M | +25% |
| Q4 2025 | $88.4M | +25% |
| Q3 2025 | $79.8M | +12% |
| Q2 2025 | $76.3M | +13% |
| Q1 2025 | $70.6M | +5.8% |
| Q4 2024 | $71M | +12% |
MCB's revenue has grown year over year for 11 quarters in a row: $101M last quarter, up 26% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 46% | +33 points |
| Q2 2026 | 30% | -5.1 points |
| Q1 2026 | 50% | +17 points |
| Q4 2025 | 47% | +2.4 points |
| Q3 2025 | 13% | -12 points |
| Q2 2025 | 35% | -0.2 points |
| Q1 2025 | 33% | -3.3 points |
| Q4 2024 | 44% | +13 points |
MCB has the edge over IREN on profitability, with a higher operating margin.
IREN Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$1.6B | -$1.6B |
| Q2 2026 | $482.2M | +2895% |
| Q1 2026 | -$873.8M | -$523.1M |
| Q4 2025 | -$468M | -$334M |
| Q3 2025 | -$38M | +$349.4M |
| Q2 2025 | $16.1M | +$179M |
| Q1 2025 | -$350.7M | -$128.7M |
| Q4 2024 | -$134M | -$105.2M |
IREN's free cash flow was −$2.5B over the past year, against −$507M the year before. Free cash flow isn't a meaningful measure for financial services companies like IREN.
MCB Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $61.5M | +93% |
| Q2 2026 | -$10.8M | -159% |
| Q1 2026 | $55M | +609% |
| Q4 2025 | $30.7M | -63% |
| Q3 2025 | $31.8M | +562% |
| Q2 2025 | $18.4M | -48% |
| Q1 2025 | $7.8M | -69% |
| Q4 2024 | $83.4M | +$114.2M |
MCB has the edge over IREN on cash generation, producing positive trailing cash flow while its opponent burns cash.
IREN Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +26% | +82.4M shares |
| 1 year | +10% | +36.9M shares |
| 3 years | +511% | +333M shares |
| 5 years | +624% | +344M shares |
| Available history | +2346% | +382M shares |
IREN has the edge over MCB on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
MCB Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +55K shares |
| 1 year | +19% | +2M shares |
| 3 years | +13% | +1.4M shares |
| 5 years | +41% | +3.7M shares |
| Available history | +51% | +4.2M shares |
MCB has 13M diluted shares, up 19% from a year ago, despite $40M in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $9.8M |
| Q2 2026 | — |
| Q1 2026 | $9.9M |
| Q4 2025 | $20.2M |
| Q3 2025 | $2.7M |
| Q2 2025 | $37.6M |
| Q1 2025 | $12.9M |
MCB spent $40M buying back its own shares over the past year.
IREN Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q1 2026 | 157.6x | High |
| Q4 2025 | 22.2x | High |
| Q3 2025 | 4.1x | High |
| Q2 2025 | 2.0x | Moderate |
| Q1 2025 | 3.3x | Elevated |
| Q4 2024 | -4.6x | Net Cash |
| Q3 2024 | -16.7x | Net Cash |
| Q2 2024 | -15.9x | Net Cash |
IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.
MCB Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.4x | Net Cash |
| Q2 2026 | -1.6x | Net Cash |
| Q1 2026 | -4.9x | Net Cash |
| Q4 2025 | -3.4x | Net Cash |
| Q3 2025 | -2.1x | Net Cash |
| Q2 2025 | 0.1x | Very low |
| Q1 2025 | -0.2x | Net Cash |
| Q4 2024 | 0.4x | Very low |
MCB has more cash than debt. Net leverage isn't a meaningful measure for financial services companies like MCB.
IREN Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 33.3 | Neutral |
| Stochastic | 8.2 | Oversold |
IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).
MCB Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 59.6 | Neutral |
| Stochastic | 78.7 | Neutral |
MCB's weekly RSI is 60 (neutral) and its Stochastic is 79 (neutral).
IREN PE vs Financial Services Sector
| Metric | IREN | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 13x | — |
IREN has no meaningful PE right now: it lost money over the past year.
MCB PE vs Financial Services Sector
| Metric | MCB | Sector median | Relative |
|---|---|---|---|
| PE | 9.9x | 13x | 24% below |
| PE % | 44 | 63 | 19 pts below |
MCB is trading at 9.9x earnings, a 24% discount to the Financial Services sector's median of 13x.
IREN Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $29.8 | 35% below |
| 20 week MA | $36.2 | 46% below |
| 50 week MA | $42.8 | 54% below |
| 100 week MA | $32.0 | 39% below |
| 200 week MA | $19.1 | 2.1% above |
IREN has fallen below most of its moving averages, though it's still 2.1% above its 200-week average.
MCB Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $92.2 | 5.3% above |
| 20 week MA | $93.0 | 4.5% above |
| 50 week MA | $89.2 | 8.9% above |
| 100 week MA | $77.8 | 25% above |
| 200 week MA | $60.9 | 60% above |
MCB has the edge over IREN on trend strength, trading above more of its moving averages.
IREN Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $24.8 | $17.2 | -31% |
| 2022 | $17.2 | $1.19 | -93% |
| 2023 | $1.19 | $7.15 | +501% |
| 2024 | $7.15 | $10.7 | +50% |
| 2025 | $10.7 | $40.3 | +276% |
| 2026 YTD | $40.3 | $19.5 | -52% |
IREN's yearly returns have swung widely, from +501% in 2023 to −93% in 2022. It's down 52% so far in 2026.
MCB Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $47.9 | $35.8 | -25% |
| 2021 | $35.8 | $100.4 | +180% |
| 2022 | $100.4 | $57.9 | -42% |
| 2023 | $57.9 | $55.4 | -4.3% |
| 2024 | $55.4 | $58.2 | +5% |
| 2025 | $58.2 | $78.3 | +35% |
| 2026 YTD | $78.3 | $97.1 | +24% |
MCB has the edge over IREN on returns for 2026, with the stronger performance.